Clinical Immunology & Research

Clinical Immunology & Research

Open Access
ISSN: 2639-8494
Research Article

An Evaluation of Maryland Providers’ Knowledge, Comfort, Likelihood of Prescribing PrEP, and Perceived Barriers and Facilitators to Prescribing PrEP

Authors: Oluwatosin H. Olateju, Sharon E. Barrett.

DOI: 10.33425/2639-8494.1046


Abstract

Purpose: To understand persisting knowledge gaps among providers in Maryland regarding HIV prevention for minors and evaluate the providers’ comfort and likelihood of prescribing oral pre-exposure prophylaxis (PrEP), and their perceived barriers and facilitating factors to prescribing PrEP.

Methods: Between January 2021 and June 2021, we conducted semistructured, audio-recorded interviews of 18 community health clinicians who provide care to adolescents in Maryland. This qualitative study was well suited as a case study. The theories that served as the primary orienting lens for this research were the theory of planned behavior, and the diffusion of innovation.

Results: A total of 18 providers participated in the study. Nine main themes emerged. While reasonable knowledge was noted among most participants regarding the concepts of PrEP, only half (50%) were knowledgeable about the Maryland Minor Consent Law (MMCL) for HIV prevention treatment. In addition, the providers had dissimilar experiences in the prescription of PrEP.

Conclusion: Most of the participants were knowledgeable about PrEP, and many were also experienced in prescribing PrEP to eligible adults. Several provider-level barriers to prescribing PrEP were reported. Consequently, the implementation of PrEP in HIV clinics may be challenging without failing to address HIV providers’ concerns.

View / Download PDF
Citation: Oluwatosin H. Olateju,  Sharon E. Barrett. An Evaluation of Maryland Providers’ Knowledge, Comfort, Likelihood of Prescribing PrEP, and Perceived Barriers and Facilitators to Prescribing PrEP. 2022; 6(1). DOI: 10.33425/2639-8494.1046
Editor-in-Chief
Jianxun Song
Jianxun Song
Microbial Pathogenesis & Immunology | Pennsylvania State University

View full editorial board →
Journal Metrics
Impact Factor 2.4*
Acceptance Rate 74%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days